Chlamydia News and Research

Latest Chlamydia News and Research

Common sexually transmitted bacterial infection more than doubles risk of HIV

A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, according to a study by researchers at RTI International.

11 Mar 2012

Infection with M. genitalium may double African women's HIV risk

A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, reports a study in the March issue of AIDS.

9 Mar 2012

FDA clears Roche's new test for detection of CT and NG infections

Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collected vaginal swabs.

1 Feb 2012

Azithromycin shows promise against trachoma-related blindness

A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually. This randomized study on trachoma, the leading cause of infection-caused blindness in the world, could potentially treat twice the number of patients using the same amount of medication.

22 Dec 2011

SMA honors JSUMC obstetrician with Robert D. and Alma W. Moreton Original Research Award

Jersey Shore University Medical Center is pleased to announce that Mark G. Martens, M.D. chairman of Department of Obstetrics and Gynecology, was honored in November by the Southern Medical Association (SMA) with the Robert D. and Alma W. Moreton Original Research Award.

21 Dec 2011

Sex statistics show a quarter of women beginning before sixteen

According an official annual health survey more than a quarter of young women today say that they first had sex when they were below the age of 16. This is much higher than statistics from the last generation. The findings of the latest survey, for 2010, suggest that sexual behavior has changed over the generations, according to the NHS Information Centre, which publishes the annual report.

18 Dec 2011

Annual report on sexually transmitted infections reveals rising trends

New figures reveal that cases of some common sexually spread diseases continue to increase in the United States. These numbers come in the annual report on sexually transmitted disease released by health officials this Thursday.

17 Nov 2011

Teenage girls with recurrent PID face fivefold risk of chronic pelvic pain and high rates of infertility

A study of the long-term consequences of pelvic inflammatory disease (PID) led by researchers at the Johns Hopkins Children's Center shows repeated bouts of the disease can double a woman's risk of infertility and quadruple her risk of chronic pelvic pain.

9 Nov 2011

First-ever phase 1 clinical trial of rectal HIV-prevention drug

A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory, according to a new study by the UCLA AIDS Institute.

9 Nov 2011

Gen-Probe receives FDA approval for APTIMA HPV assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has approved its APTIMA HPV assay, an amplified nucleic acid test that detects high-risk strains of human papillomavirus (HPV) that are associated with cervical cancer and precancerous lesions.

31 Oct 2011

Impact of pelvic inflammatory disease on teen girls underestimated

A Johns Hopkins Children's Center study comparing perceptions of pelvic inflammatory disease (PID) among teen girls and parents has found that parents seriously underestimate the emotional and medical impact this sexually transmitted disease has on teenagers.

28 Oct 2011

Breakthrough in the study of chlamydia genetics

A breakthrough in the study of chlamydia genetics could open the way to new treatments and the development of a vaccine for this sexually transmitted disease.

13 Oct 2011

Study finds experimental vaccine protects monkeys from blinding trachoma

"An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National Institutes of Health (NIH) study in monkeys," an NIH press release reports.

12 Oct 2011

Potential vaccine against trachoma

An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National Institutes of Health study in monkeys.

10 Oct 2011

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

29 Sep 2011

Aborigines have higher STD rates than general Australian population

Aborigines in Australia have higher rates of sexually transmitted diseases such as gonorrhea, syphilis, and chlamydia than the country's general population, according to research by the University of New South Wales' Kirby Institute and reported on Tuesday at a sexual health conference, the Associated Press/Seattle Times reports.

29 Sep 2011

UCI professor wins Presidential Early Career Award for Scientists & Engineers

Rommie Amaro, UC Irvine assistant professor of pharmaceutical sciences and computer science, has been selected by President Obama for the Presidential Early Career Award for Scientists & Engineers.

28 Sep 2011

Health Canada grants medical device licence to Gen-Probe's PANTHER system

Gen-Probe Incorporated announced today that Health Canada has granted the Company a medical device license for the PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.

23 Aug 2011

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.

23 Aug 2011